Predicting methicillin resistance among community-onset Staphylococcus aureus bacteremia patients with prior healthcare-associated exposure

被引:4
|
作者
Chen, S. -Y. [1 ,2 ]
Chiang, W. -C. [1 ,2 ]
Ma, M. H. -M. [2 ]
Hsueh, P. -R. [3 ]
Chang, S. -C. [4 ]
Fang, C. -C. [2 ]
Chen, S. -C. [2 ]
Chen, W. -J. [2 ]
Chie, W. -C. [1 ]
Lai, M. -S. [1 ]
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med & Internal Med, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
关键词
BLOOD-STREAM INFECTIONS; RISK-FACTORS; EMERGENCY-DEPARTMENT; UNITED-STATES; PNEUMONIA; VANCOMYCIN; MORTALITY; METAANALYSIS; PREVALENCE; STRAINS;
D O I
10.1007/s10096-012-1621-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To develop and validate prediction rules to identify the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection among community patients who have healthcare-associated (HA) exposure and S. aureus bacteremia. A total of 1,166 adults with community-onset S. aureus bacteremia were retrospectively enrolled. The background prevalence of community MRSA infection was extrapolated from 392 community-associated S. aureus bacteremia (CA-SAB) patients without HA exposure. Complete and clinical risk scores were derived and tested using data from 774 healthcare-associated S. aureus bacteremia (HA-SAB) patients. The risk scores were modeled with and without incorporating previous microbiological data as a model predictor and stratified patients to low-, intermediate-, and high-risk groups for MRSA infection. The clinical risk score included five independent predictors and the complete risk score included six independent predictors. The clinical and complete risk scores stratified 32.7 % and 42.0 % of HA-SAB patients to the low-risk group for MRSA infection respectively. The prevalence of MRSA infection in score-stratified low-risk groups ranged from 16.3 % to 23.3 %, comparable to that of CA-SAB patients (13.8 %). Simple decision rules allow physicians to stratify the risk of MRSA infection when treating community patients with prior HA exposure and possible S. aureus infection.
引用
收藏
页码:2727 / 2736
页数:10
相关论文
共 50 条
  • [31] Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
    Lodise, TP
    McKinnon, PS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (02) : 113 - 122
  • [32] Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared
    Day, Shandra R.
    Moore, Christopher M.
    Kundzins, John R.
    Sifri, Costi D.
    VIRULENCE, 2012, 3 (07) : 576 - 582
  • [33] Mupirocin and Chlorhexidine Resistance in Staphylococcus aureus in Patients with Community-Onset Skin and Soft Tissue Infections
    Fritz, Stephanie A.
    Hogan, Patrick G.
    Camins, Bernard C.
    Ainsworth, Ali J.
    Patrick, Carol
    Martin, Madeline S.
    Krauss, Melissa J.
    Rodriguez, Marcela
    Burnham, Carey-Ann D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 559 - 568
  • [34] Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality
    Maseda, Emilio
    Ramirez, Sofia
    Picatto, Pedro
    Pelaez-Pelaez, Eva
    Garcia-Bernedo, Carlos
    Ojeda-Betancur, Nazario
    Aguilar, Gerardo
    Fores, Beatriz
    Solera-Marin, Jorge
    Aliano-Pina, Maria
    Tamayo, Eduardo
    Ramasco, Fernando
    Garcia-Alvarez, Raquel
    Gonzalez-Lisorge, Ada
    Gimenez, Maria-Jose
    Suarez-de-la-Rica, Alejandro
    PLOS ONE, 2019, 14 (09):
  • [35] Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia
    Cheong, Hae Suk
    Kang, Cheol-In
    Kwon, Ki Tae
    Heo, Sang Tack
    Wi, Yu Mi
    Kim, Eun Seok
    Lee, Jin Seo
    Ko, Kwan Soo
    Chung, Doo Ryeon
    Lee, Nam Yong
    Song, Jae-Hoon
    Peck, Kyong Ran
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1355 - 1360
  • [36] Utility of prior screening for methicillin-resistant Staphylococcus aureus in predicting resistance of S. aureus infections
    MacFadden, Derek R.
    Elligsen, Marion
    Robicsek, Ari
    Ricciuto, Daniel R.
    Daneman, Nick
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (15) : E725 - E730
  • [37] The Impact of Healthcare-Associated Methicillin-Resistant Staphylococcus Aureus Infections on Post-Discharge Healthcare Costs and Utilization
    Nelson, Richard E.
    Jones, Makoto
    Liu, Chuan-Fen
    Samore, Matthew H.
    Evans, Martin E.
    Graves, Nicholas
    Lee, Bruce
    Rubin, Michael A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (05) : 534 - 542
  • [38] Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis
    Young Kyung Yoon
    Dae Won Park
    Jang Wook Sohn
    Hyo Youl Kim
    Yeon-Sook Kim
    Chang-Seop Lee
    Mi Suk Lee
    Seong-Yeol Ryu
    Hee-Chang Jang
    Young Ju Choi
    Cheol-In Kang
    Hee Jung Choi
    Seung Soon Lee
    Shin Woo Kim
    Sang Il Kim
    Eu Suk Kim
    Jeong Yeon Kim
    Kyung Sook Yang
    Kyong Ran Peck
    Min Ja Kim
    BMC Infectious Diseases, 16
  • [39] Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus Strains as a Cause of Healthcare-Associated Bloodstream Infections in Korea
    Park, Sun Hee
    Park, Chulmin
    Yoo, Jin-Hong
    Choi, Su-Mi
    Choi, Jung-Hyun
    Shin, Hyun-Ho
    Lee, Dong-Gun
    Lee, Seungok
    Kim, JaYoung
    Rn, So Eun Choi
    Kwon, Young-Mi
    Shin, Wan-Shik
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (02) : 146 - 155
  • [40] Infection preventiondhow can we prevent transmission of community-onset methicillin-resistant Staphylococcus aureus?
    Kao, Carol M.
    Fritz, Stephanie A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2025, 31 (02) : 166 - 172